FDA — authorised 9 February 1977
- Application: ANDA061976
- Marketing authorisation holder: APOTHECON
- Local brand name: VELOSEF
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Cephradin on 9 February 1977
Yes. FDA authorised it on 9 February 1977; FDA has authorised it.
APOTHECON holds the US marketing authorisation.